Pancreatic Cancer Research

ResearcherUniversity of UtahActive in the last 2 years

Antonio Facciorusso

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2107-2156; OpenAlex author ID A5010071655. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 4 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis. Co-author DOI 10.1016/j.pan.2026.04.005↗
  2. Reducing the incidence of pancreatic cancer through radiofrequency ablation of mucinous cystic neoplasms: What is the evidence? Last author DOI 10.1016/j.bpg.2025.101986↗
  3. Endoscopic Ultrasound-Guided Treatments for Pancreatic Cancer: Understanding How Endoscopic Ultrasound Has Revolutionized Management of Pancreatic Cancer. First author DOI 10.3390/cancers17010089↗
  4. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer. Co-author DOI 10.1016/j.surg.2023.01.016↗
  5. Rising Incidence of Pancreatic Cancer in Patients 20 to 39 Years: A Population-Based Observational Study. First author DOI 10.1097/mpa.0000000000002231↗
  6. New Perspectives on Endoscopic Management of Liver and Pancreatic Cancer. Last author DOI 10.3390/cancers15051549↗
  7. Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer. Co-author DOI 10.3390/ijms241612681↗
  8. Association of BRCA Mutations and Pancreatic Cancer: Review of Literature and Meta-analysis. Co-author DOI 10.1097/mpa.0000000000001956↗
  9. Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis. Co-author DOI 10.4103/eus.eus_24_20↗
  10. Response to repeat echoendoscopic celiac plexus neurolysis in pancreatic cancer patients: A machine learning approach. Co-author DOI 10.1016/j.pan.2019.07.038↗
  11. Echoendoscopic ethanol ablation of tumor combined with celiac plexus neurolysis in patients with pancreatic adenocarcinoma. Co-author DOI 10.1111/jgh.13478↗
  12. Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma. Co-author DOI 10.4103/2303-9027.170428↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daryl Ramai · 3 shared papers, 2022–2023 · strength 0.69
  2. Nicola Muscatiello · 4 shared papers, 2015–2020 · strength 0.47
  3. Matteo Tacelli · 1 shared paper, 2026 · strength 0.39
  4. Gaetano Lauri · 1 shared paper, 2026 · strength 0.39
  5. Gabriele Capurso · 1 shared paper, 2026 · strength 0.39
  6. Paolo Giorgio Arcidiacono · 1 shared paper, 2026 · strength 0.39
  7. Jorge D. Machicado · 1 shared paper, 2025 · strength 0.28
  8. Pujitha Kudaravalli · 1 shared paper, 2025 · strength 0.28
  9. Stefano Francesco Crinò · 1 shared paper, 2025 · strength 0.28
  10. Monique T. Barakat · 1 shared paper, 2023 · strength 0.26
  11. Phil A. Hart · 1 shared paper, 2023 · strength 0.26
  12. Barbara Lattanzi · 1 shared paper, 2023 · strength 0.24
  13. Sahib T Singh · 1 shared paper, 2024 · strength 0.23
  14. Dushyant Singh Dahiya · 1 shared paper, 2024 · strength 0.23
  15. Sudhir Dutta · 1 shared paper, 2024 · strength 0.23
  16. Sumant Inamdar · 1 shared paper, 2024 · strength 0.23
  17. Neil R Sharma · 1 shared paper, 2024 · strength 0.23
  18. Gursimran Singh Kochhar · 1 shared paper, 2022 · strength 0.19
  19. Saurabh Chandan · 1 shared paper, 2022 · strength 0.19
  20. Anna Maria Ierardi · 1 shared paper, 2023 · strength 0.18
  21. Gianpaolo Carrafiello · 1 shared paper, 2023 · strength 0.18
  22. Maria Caterina De Grandis · 1 shared paper, 2023 · strength 0.18
  23. Michele Ghidini · 1 shared paper, 2023 · strength 0.18
  24. Alberto Larghi · 1 shared paper, 2017 · strength 0.08
  25. Guido Costamagna · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.